Mechanisms of acquired resistance to MET tyrosine kinase inhibitors (TKIs) in MET exon 14 (METex14) mutant non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2018 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results